This is to inform you that USFDA had conducted an inspection at the Company''s manufacturing facility located at Baddi from 19th March, 2024 to 27th March, 2024. At the end of the inspection, the Company has received Form 483 with 10 observations. This was a GMP as well as a Pre-Approval inspection. There is no data integrity observation.